Adempas and Systemic sclerosis (scleroderma) - a phase IV clinical study of FDA data
Summary:
Systemic sclerosis (scleroderma) is reported as a side effect among people who take Adempas (riociguat), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Opsumit, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Systemic sclerosis (scleroderma) when taking Adempas. It is created by eHealthMe based on reports of 29,726 people who have side effects when taking Adempas from the FDA, and is updated regularly.
What is Adempas?
Adempas has active ingredients of riociguat. eHealthMe is studying from 29,741 Adempas users. Check the latest studies of Adempas.
What is Systemic sclerosis (scleroderma)?
Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 493 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29,726 people reported to have side effects when taking Adempas.
Among them, 125 people (0.42%) have Systemic sclerosis (scleroderma).
/could-adempas-cause-systemic-sclerosis-(scleroderma).png "Could Adempas cause Systemic sclerosis (scleroderma)?")
Among these 125 people:
How long have people been on Adempas when they have Systemic sclerosis (scleroderma)? *
What is the gender of people who have Systemic sclerosis (scleroderma) when taking Adempas? *
What is the age of people who have Systemic sclerosis (scleroderma) when taking Adempas? *
What are other drugs people take besides Adempas? *
What are other side effects people have besides Systemic sclerosis (scleroderma)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Adempas and have Systemic sclerosis (scleroderma)?
- Check whether Systemic sclerosis (scleroderma) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Adempas:
- Adempas (29,741 reports)
Systemic sclerosis (scleroderma) treatments and more:
- Systemic sclerosis (scleroderma) (10,958 reports)
How severe was Systemic sclerosis (scleroderma) and when was it recovered:
Expand to all the drugs that have ingredients of riociguat:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adempas:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Systemic sclerosis (scleroderma):
- Systemic sclerosis (scleroderma) (493 drugs)
Browse all the conditions that are associated with Systemic sclerosis (scleroderma):
- Systemic sclerosis (scleroderma) (857 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on riociguat (the active ingredients of Adempas) and Adempas (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycodone and Coq10 drug interactions for men aged 50-59 - 5 seconds ago
- Mouth Ulceration Aggravated and drugs of ingredients of rituximab - 5 seconds ago
- Could Idamycin cause White Blood Cell Count Decreased? - 8 seconds ago
- Could Bisoprolol Fumarate cause Cough Aggravated? - 10 seconds ago
- Tamoxifen Citrate and Levothyroxine Sodium drug interactions for women aged 50-59 - 11 seconds ago
- Drug interactions of Myfortic and Everolimus - 17 seconds ago
- Clonidine and Zegerid drug interactions for women aged 50-59 - 18 seconds ago
- Could Linzess cause Dizziness Aggravated? - 22 seconds ago
- Could Humira cause Dacryostenosis Acquired? - 22 seconds ago
- Capoten vs. Propranolol Hydrochloride, side effect and effectiveness comparison - 26 seconds ago